Targeting brain’s immune cells may block Alzheimer’s

A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.

Moonshadow joins ‘galaxy’ of colorful tomatoes

Moonshadow, a new variety of grape tomato, is a high-flavor, traditionally bred tomato derived from crosses with heirloom varieties. It’s aimed at organic growers, small farms and home gardeners.     

Q&A: COVID-19 and public health investment

For physician and epidemiologist Dr. Jay Varma, the COVID-19 pandemic underscores not only the importance of public health, but also the powerful and pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.

Immune cells may trigger inflammation in MS

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine researchers.

Forum showcases community-engaged learning projects

Examples of how community-engaged learning projects can address community needs were showcased during a virtual forum on Nov. 17. The projects demonstrate the College of Human Ecology’s Engaged College Initiative, a partnership between the college and the David M. Einhorn Center for Community Engagement that supports learning with a community engagement component.

Around Cornell

Students present projects in global and public health

The 2021 Global and Public Health Experiential Learning Symposium featured projects aimed at improving access to public health everywhere from Tompkins County to Tanzania.

Antibodies help keep harmful forms of gut fungi in check

Antibody protection against harmful forms of fungi in the gut may be disrupted in some patients with Crohn’s disease – a condition caused by chronic inflammation in the bowel – according to a new study by Weill Cornell Medicine investigators.

Department of Defense funds research on rare eye condition

Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.

Leveraging tech for meaningful work

Employers who use technological advancement to reshape workers’ jobs can help improve patient care while improving the work experience of frontline health care workers, Associate Professor Adam Seth Litwin argues in a peer-reviewed commentary.

Around Cornell